NCT02458027

Brief Summary

The objectives of this trial are to investigate whether the effects of hemp protein on glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin and appetite for one hour following consumption, 2) blood glucose, insulin and appetite following a fixed energy meal to determine the "second meal effect" of hemp protein versus soybean protein and a non-protein control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 29, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2016

Completed
Last Updated

March 23, 2023

Status Verified

April 1, 2021

Enrollment Period

1 year

First QC Date

May 27, 2015

Last Update Submit

March 20, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Plasma Glucose and Insulin Concentrations

    Measured in blood using intravenous catheter at 12 time points, used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits. (Composite measure)

    0-200 minutes

  • Appetite

    Measured by VAS Questionnaire.

    0-200 minutes

  • Food Intake

    Measured by fixed energy meal.

    0-200 minutes

  • Blood Pressure

    Measured by automated bood pressure cuff.

    0-200 minutes

Secondary Outcomes (3)

  • Palatability of Treatments and Meal

    5-80 minutes

  • Physical Comfort

    0-200 minutes

  • Energy/Fatigue

    0-200 minutes

Study Arms (5)

20g Hemp Protein Shake

EXPERIMENTAL

Hemp protein shake, 20 grams, given once at beginning of acute trial.

Dietary Supplement: Hemp Shake

40 g Hemp Protein

EXPERIMENTAL

Hemp protein shake, 40 grams, given once, at beginning of acute trial.

Dietary Supplement: Hemp

20 g Soybean Protein Shake

ACTIVE COMPARATOR

Soybean protein shake, 20 grams, given once, at beginning of acute trial.

Dietary Supplement: Soybean Shake

40 g Soybean Protein

EXPERIMENTAL

Soybean protein shake, 40 grams, given once, at beginning of acute trial.

Dietary Supplement: Soybean

Control Shake

PLACEBO COMPARATOR

Non-protein control shake, given once, at beginning of acute trial.

Dietary Supplement: Control

Interventions

Hemp ShakeDIETARY_SUPPLEMENT

Hemp Protein

20g Hemp Protein Shake
HempDIETARY_SUPPLEMENT

Hemp Protein Shake

40 g Hemp Protein
Soybean ShakeDIETARY_SUPPLEMENT

Soybean Protein

20 g Soybean Protein Shake
SoybeanDIETARY_SUPPLEMENT

Soybean Protein Shake

40 g Soybean Protein
ControlDIETARY_SUPPLEMENT

Non-Protein Shake

Control Shake

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normoglycemic (\<5.6 mmol/L)
  • Body mass index (BMI) of 18.5-29.9 kg/m2.

You may not qualify if:

  • Restrained eaters
  • Regularly skip breakfast
  • Smokers
  • Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Richardson Centre for Functional Foods and Nutraceuticals

Winnipeg, Manitoba, R3T 2N2, Canada

Location

Study Officials

  • Peter Jones, Ph.D.

    University of Manitoba, Richardson Centre for Functional Foods and Nutraceuticals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2015

First Posted

May 29, 2015

Study Start

July 1, 2015

Primary Completion

July 13, 2016

Study Completion

July 13, 2016

Last Updated

March 23, 2023

Record last verified: 2021-04

Locations